The use of human neural progenitor cells (hNPC) has been proposed to provide neuronal replacement or astrocytes delivering growth factors for brain disorders such as Parkinson's and Huntington's disease. Success in such studies likely requires migration from the site of transplantation and integration into host tissue in the face of ongoing damage. In the current study, hNPC modified to release glial cell line-derived neurotrophic factor (hNPC GDNF ) were transplanted into either intact or lesioned animals. GDNF release itself had no effect on the survival, migration, or differentiation of the cells. The most robust migration and survival was found using a direct lesion of striatum (Huntington's model) with indirect lesions of the dopamine system (Parkinson's model) or intact animals showing successively less migration and survival. No lesion affected differentiation patterns. We conclude that the type of brain injury dictates migration and integration of hNPC, which has important consequences when considering transplantation of these cells as a therapy for neurodegenerative diseases.
INTRODUCTION
cells from primary rodent and human brain tissue (1,28). Some studies have shown that transplantation of neural stem or progenitor cells into nonneurogenic regions of The possibility of using transplantation therapies for the treatment of both Parkinson's disease and Hunting-the adult intact brain leads to the generation of mainly astrocytes (31) , unless the cells are first predifferentiated ton's disease has been widely discussed (3, 8) . This may be to either replace damaged neurons, which would re-into postmitotic neurons in vitro (4). Other studies have transplanted neural stem and progenitor cells into areas quire neuronal differentiation and integration, or provide supportive glial cells that secrete trophic factors such as of the adult brain undergoing active neurogenesis, such as the hippocampus and subventricular zone, and shown GDNF that are known to promote the survival of degenerating neurons (26). Clearly, both the cell source and that the cells identify on local cues and follow endogenous patterns of proliferation and differentiation into the host environment will dictate how and if the cells integrate and survive. Early studies where primary ro-neurons (7, 10, 24) . In some cases these cells have been shown to survive for extended periods of time and inte-dent fetal brain tissue (which contains a mixture of stem cells, progenitor cells, and terminally differentiated grate well into the host brain tissue (16) . Thus, the environment seems to play a crucial role in the survival and cells) was grafted into the striatum have shown that mild to moderate lesions can significantly increase the sur-differentiation of both primary fetal tissue and stem or progenitor cell transplants, which have the potential to vival of the transplants (29) . This was presumably due to a combination of chemokine and growth factor release at form long-term grafts within the brain. As Parkinson's and Huntington's diseases involve the the injury site supporting the new cells, in addition to the creation of more physical space within the brain due loss of different sets of neurons within the brain, it is likely that the transplanted stem or progenitor cells will to the lesion.
Recent developments in tissue culture methods have react differently to the two environments. Furthermore, modifying the cells to release factors such as GDNF allowed the expansion of neural stem and progenitor 754 BEHRSTOCK ET AL. may affect their survival and integration. However, there 6-OHDA resuspended in 0.9% saline with 0.2 µg ascorbic acid. Injections of 7 µg/3.5 µl were made over are no systematic studies that have tested how identical sets of neural stem or progenitor cells survive, migrate, three sites into the striatum (calculated from bregma): AP +1.0, ML −3.0, DV −5.0; AP −0.1 quinolinic acid integrate, and differentiate when transplanted into these two models, or how GDNF may affect this process. To (QA), ML −3.7, DV −5.0; AP −1.2, ML −4.5, DV −5.0. For QA lesions, adult male Lewis rats (300-350 g) re-test this we generated a line of human neural progenitor cells (33) that were also modified to release GDNF (2) ceived a single 200 nM injection of QA into the striatum at AP +0.48, ML −3.0, DV −5.0 from bregma. Animals and showed that their survival and migration, but not differentiation, were critically dependent on the type of received cell transplants into the striatum 1 week following the lesion. lesion environment they were exposed to, but not on the release of GDNF.
Cell Transplants MATERIALS AND METHODS
Cells were plated as neurospheres for 1 week in B27 Cell Growth differentiation media supplemented with cilliary neuro-Human cortical neural progenitor cells were isolated trophic factor (5 ng/µl, R&D). To prepare cells for transfrom primary human fetal cortex between 10 and 15 plantation, medium was removed, cells were rinsed, and weeks of gestation according to protocols approved by accutase was added for 15 min at 37°C to detach plated the NIH and local ethics committee at the University of spheres from the T75 flask. hNPC WT or hNPC GDNF were Wisconsin Madison and by the University of Washingcollected and centrifuged at 1000 rpm for 5 min. The ton Birth Defects Laboratory. Following dissociation in accutase was then removed, and the cells were rinsed in 0.1% trypsin, cells were seeded at 200,000 cells/ml in plating media. Cells were then incubated in DNAase for T75 flasks containing DMEM/Ham's F12 (Gibco-BRL) 10 min at 37°C, centrifuged at 1000 rpm for 5 min, and supplemented with penicillin/streptomycin (1%, Gibothe DNAase was removed before the cells were dissoci-BRL), N2 (1%, Gibco-BRL), epidermal growth factor ated in Liebovitz/0.6% glucose (1:1) supplemented with (20 ng/ml, Sigma) with heparin (5 µg/ml, Sigma), and B27 (1:50). Cells were then counted, centrifuged at 1000 fibroblast growth factor-2 (20 ng/ml, R&D). Neurorpm for 5 min, resuspended at 66,500/µl in fresh Liesphere colonies rapidly formed and were expanded by bovitz/0.6% glucose/B27, and maintained on ice. chopping using an automated tissue chopper as de-Control nonlesioned rats were transplanted with scribed in detail previously (27) . At 10 weeks the cells hNPC GDNF at one site (AP −0.3, ML −3.6, DV −5.2). In were switched to medium containing LIF (10 ng/ml, QA-lesioned rats, hNPC WT (n = 7) or hNPC GDNF (n = 7) Chemicon) and under these conditions the cultures could were transplanted into one site at AP −0.3, ML −3.6, be grown for at least another 30 weeks in a relatively DV −5.2. Another group received QA lesion but no stable form based on gene expression patterns and diftransplant (n = 5). In 6-OHDA-lesioned rats, hNPC GDNF ferentiation potential (32).
(n = 6) were transplanted into one site at AP 0.3, ML −3.5, DV −5.2. A 10-µl Hamilton syringe was lowered Lentiviral Infection from dura, left in place for 1 min before injecting 3 µl As described in detail previously (5), the mouse phoof cells over 3 min, and retracted after an additional 3 sphoglycerate kinase 1 (PGK) promoter (strong constitumin. Animals were injected with cyclosporine (10 mg/ tive promoter) drives the tetracycline transactivator kg, IP) 1 day before and every day following transplan-(tTA1) in the lenti-tTA construct. The tTA1 binds to the tation. At 7 weeks posttransplantation animals were pertetracycline operon that is upstream of a minimal profused with chilled 0.9% saline and 4% paraformaldemoter driving GDNF in the lenti-GDNF construct. The hyde. Brains were cryoprotected in 30% sucrose with lentiviral particles were suspended in 1% fetal bovine 0.1% sodium azide, and sectioned to 40 µm using a slidserum albumin in phosphate-buffered saline. For lentiviing microtome. rus infection, neurospheres were dissociated to single cells and infected with 5 ng of lenti-GDNF and 10 ng Immunohistochemistry of lenti-tTA per 10 5 cells for 24 h before the virus was Sections were stained for human nuclei (mouse 1:200, diluted out with fresh medium (2). New spheres then Chemicon) or GDNF (goat 1:250, R&D). For human formed through aggregation and were allowed to expand nuclei, sections were rinsed in Tris-HCl, incubated in before transplantation. Noninfected wild-type hNPC 2N HCl for 30 min at 37°C, quenched in 5% H 2 O 2 and (hNPC WT ) were grown in parallel.
10% methanol, and blocked in 10% normal horse serum Partial 6-OHDA and QA Lesions prior to primary antibody. Biotinylated mouse secondary (1:2000, Vector Labs) and ABC (Vectastain kit) were Adult male Lewis rats (300-350 g) were injected with a total of 21 µg of 6-hydroxydopamine (6-OHDA) followed by DAB (Sigma tablets) development. For hu-man GDNF, sections were rinsed in TBS containing Triton, ity of this marker (data not shown). GDNF immunohistochemistry revealed local expression around the quenched in 0.1 M sodium periodate, and blocked in 3% NHS and 2% BSA prior to primary antibody. Biotinyl-transplantation site in the hNPC GDNF group, but not the hNPC WT group (Fig. 1C, D) , which correlated exactly ated goat secondary (1:200, Vector Labs) and ABC were followed by DAB development with nickel ammonium with the hNuc staining. This showed the hNPC WT do not release GDNF. sulfate enhancement. For double labeling with human nuclei and nestin, GFAP, or NeuN, sections were pro-
The average number of hNuc-positive cells was not significantly different between the transplant groups (31,076 ± cessed as above, but primary antibodies for human nuclei, nestin (rabbit 1:200, Chemicon), GFAP (rabbit 1:
3,002 for hNPC WT , 23,766 ± 3,181 for hNPC GDNF ) ( Fig.  1E) . Similarly, there was no difference in the anterior-500, DAKO), and NeuN (mouse 1:100, Chemicon) were followed by mouse AF546-and rabbit AF488-conju-posterior distribution based on area under the curve calculations of the number of hNuc-positive cells observed gated secondary antibodies (1:500, Molecular Probes). in brain slices (1241.0 ± 119.8 hNPC WT , 942.8 ± 121.0 Cell Counts hNPC GDNF hNuc-positive cells/mm) ( Fig. 1F ). Double la-All human nuclei-positive cells were counted in evbeling with hNuc and antibodies to either nestin or glial ery sixth section of every rat in each group through the fibrillary acidic protein (GFAP) revealed that the vast marostral/caudal extent of the striatum beginning in secjority of hNuc-positive cells in both groups remained nestin tions containing the anterior portion of the lateral ventripositive (92.3 ± 0.88% hNPC WT , 91.6 ± 1.4% hNPC GDNF ) cle to the hippocampus. For counts using confocal micro-( Fig. 2A, B ), whereas only a small proportion were posiscopy, human nuclei-positive cells colabeled with either tive for both hNuc and GFAP (7.5 ± 0.5% hNPC WT , 8.6 GFAP or nestin were counted in randomly selected sec-± 1.2% hNPC GDNF ) ( Fig 2C, D) . There were no hNuctions for four rats in each group. Cell counts ranged positive cells that coexpressed NeuN to label neurons from approximately 200 to 500.
(data not shown). Together these data show that GDNF releasing hNPC behave in an identical fashion to wild-Data Analysis type hNPC following transplantation into the lesioned Human nuclei, nestin, and GFAP cell counts were all striatum. analyzed by one-way ANOVA or Student's t-test. Hu-
The Lesion Environment Controls the Survival man nuclei-positive cell distribution was analyzed by and Migration of hNPC GDNF area under the curve calculations performed in Prism. All data are presented as ±SEM.
We next addressed how the lesion environment may modify cell survival, migration, and differentiation.
RESULTS
hNPC GDNF were transplanted into the striatum of intact Infection of hNPC With Lenti-GDNF Does Not Affect rats (n = 7) and 7 days following either 6-OHDA (n = Their Survival, Migration, or Differentiation Following 6) or QA (n = 7) lesions. All three groups showed sur-Transplantation Into QA-Lesioned Rats viving cells within the transplant with hNuc immunohistochemistry ( Fig. 3A-C ). Furthermore, GDNF protein We have previously shown that wild-type (WT) hNPC not modified to release GDNF can survive and was observed in the striatum in the area immediately surrounding the transplant site with a gradient of expres-migrate within the striatum of rats lesioned with either quniolinic acid (17) or 6-OHDA (2). However, we did sion further from the core (Fig. 3D-F ). However, there was considerably more spread of the cells away from the not assess the possible effects of GDNF itself on the survival, migration, or differentiation following trans-graft site in the QA-lesioned animals when compared to the 6-OHDA-lesioned animals, and even more so com-plantation. To address this question, adult rats (n = 19) were lesioned with an intrastriatal injection of QA. Sta-pared to nonlesioned animals ( Fig. 3G-I) . The migration of cells was not simply diluting out the total number ble lines of hNPC expressing GDNF were generated as described previously (2) and grown for 9 weeks in vitro.
of cells transplanted as counts revealed that there were significantly more hNuc-positive hNPC GDNF in the QA-One week following the lesion, either hNPC WT (n = 7) or hNPC GDNF (n = 7) were transplanted into the striatum lesioned rats compared to 6-OHDA-lesioned rats and intact animals (23,766 ± 3,181 QA, 14,194 ± 1,899 6-surrounding the lesion site. Five rats were used as notransplant lesion controls. All animals were treated daily OHDA, 6,306 ± 1,326 nonlesioned) ( Fig. 3J ). Moreover, cells in the QA-lesioned brain showed a preference for with cyclosporine and sacrificed at 7 weeks postlesion. Using the specific human nuclear antigen marker (hNuc), the collapsed gray matter within the striatum, whereas cells in the 6-OHDA-lesioned and unlesioned brain pri-substantial transplants were evident in both groups of transplanted rats (Fig. 1A, B ), but no cells were seen marily remained in the transplant core and/or migrated into white matter tracts ( Fig. 4A-C) . in the nontransplanted controls, confirming the specific- (A, B) , but only the cells infected with lenti-GDNF express GDNF in the area immediately surrounding the transplant (C, D). Counts of hNuc-positive cells showed no difference in total survival (E) or migration through the striatum (F) between hNPC WT and hNPC GDNF . Scale bar: 50 µm.
The Differentiation of hNPC GDNF Is Not Affected
(2,14,17), very few of the hNPC GDNF matured into neurons under these conditions, and this was not affected by by the Lesion Environment the lesion type (data not shown). Confocal microscopic analysis of immunofluorescent labeling for human nu-We next asked whether the lesion environment had any effect on the maturation of the cells into neurons or clei and either nestin or GFAP showed that approximately 90% of the hNuc-positive cells remained nestin astrocytes. In agreement with our previous studies positive (91.6 ± 1.4% QA, 88.7 ± 2.2% 6-OHDA, 90.4 ± fact that the source of stem cells in each study is often very different with regard to region of origin, age of 2.6% unlesioned), and only a small proportion of hNucpositive cells colabeled with GFAP (8.6 ± 1.2% QA, 6.6 ± donor, species of donor, and in some cases immortalizing agents that were used. However, in most cases when 1.9% 6-OHDA, 8.3 ± 1.2% unlesioned) (Fig. 5A, B) . We conclude that the lesion, while affecting the overall a nonlesion environment is compared to a lesioned environment, the stem cells show better survival and inte-survival and migration of the hNPC GDNF , did not affect their default nestin-positive status or enhance their dif-gration into the host tissue when transplanted into a lesioned, but nonnecrotic, environment. For example, ferentiation into neurons or GFAP-positive astrocytes.
immortalized neural stem cells will migrate towards DISCUSSION damage in the brain caused by hypoxia (21) , and human neural stem cells migrate towards damage induced by In the current study, we show that direct lesions of cell bodies in the striatum provide an enhanced environ-stroke, but do not survive well if placed in the necrotic core (12) . Similarly, in the shiverer mouse, which has ment for stem cell survival compared to either terminal lesions of dopamine fibers in the striatum or an intact excessive white matter damage to model diseases of the myelin sheath, human neural stem cells isolated from striatum. Neural stem cells have been transplanted into a wide variety of disease models with many different either the adult or developing brain survive and integrate well after transplantation (30). In models of multiple reported outcomes. Interpretation is complicated by the Figure 2 . Lenti-GDNF infection does not alter differentiation potential of transplanted hNPC. Confocal microscopy and subsequent quantification showed that the vast majority (92.3 ± 0.88% hNPC WT , 91.6 ± 1.4% hNPC GDNF ) of transplanted hNPC remained nestin positive (A, B) and only approximately 8% of hNuc-positive cells colabeled with GFAP (7.5 ± 0.5% hNPC WT , 8.6 ± 1.2% hNPC GDNF , C and D) regardless of infection with a lentivirus encoding GDNF. Only a negligible amount of hNuc-positive cells double labeled with NeuN (<1%; data not shown). There is no significant difference for either the nestin or GFAP results. The type of lesion dramatically affected the migration and survival of GDNF expressing hNPC. hNPC GDNF transplanted into the striatum of QA-lesioned (A), 6-OHDA-lesioned (B), or unlesioned (C) rats survived and expressed GDNF in the area surrounding the transplant core with a gradient of GDNF expression further from the core (D-F). hNPC GDNF transplanted into the striatum of QA-lesioned rats migrated significantly further in the QA-lesioned brain than in either the 6-OHDA-lesioned or unlesioned brains (using area under the curve measurements (hNuc+ cells/mm 2 ) (G-I). The graphs in (G) to (I) show the number of cells that were counted in each brain section of individual rats within each group. hNuc-positive cells were found in 15 consecutive sections in the QA-lesioned rats compared to 12 in the 6-OHDA rats and 7 in the unlesioned rats. The average area under the curve value (J) shows the transplant distribution for the three groups (942.8 ± 121.0 QA, 564.3 ± 76.4 6-OHDA, 240.6 ± 51.6 unlesioned; #p < 0.05 compared to 6-OHDA and unlesioned; *p < 0.05 compared to unlesioned). Furthermore, significantly more hNPC GDNF survived in the QA-lesioned brain compared to hNPC GDNF in both the 6-OHDA and unlesioned brain (J, #p < 0.05). hNPC GDNF transplanted into 6-OHDA rats survived better than in unlesioned rats (J, *p < 0.05). The hole visible in D (and also present in A) could be necrotic tissue at the site of QA injection. Scale bar: 50 µm. sclerosis, stem cells can migrate in from the periphery While the lesion environment increased survival and migration, it did not affect the maturation of the cells to the central nervous system in response to neuronal injury, inflammation, and damage to the blood-brain into either neurons or GFAP-positive astrocytes. A recent study showed differentiation of neural stem cells barrier (22). We have previously shown that when mutant SOD1 is expressed in rats the environment around derived from human embryonic stem cells at 6 weeks posttransplant in a QA-lesioned adult rat striatum (11) . degenerating motor neurons encourages the survival and migration of hNPC releasing GDNF (14) . The exact sig-Our results could differ from this report because of the cell type and total number transplanted. Furthermore, nals released by the damaged brain that encourage stem cell migration and survival remain to be established, al-hNPC require one round of final cell division to produce neurons within a neurogenic environment (19, 20) . We though release of growth factors such as IGF-1 or specific chemoattractants from damaged tissues may play a hypothesize that the intact or lesioned brain environment does not provide those signals, which results in a block crucial role (34, 35) . Furthermore, neural stem cells express CXC chemokine receptor 4 (CXCR4) on their on division and differentiation into neurons. Clearly, transplantation of similar cells into a neurogenic envi-surface, which may home in to the ligand stromal cellderived factor-1α that is upregulated in areas of inflam-ronment, such as the neonatal rat brain, subventricular zone of the forebrain, or the hippocampus, does lead to mation (9) . Further experiments will be required to establish why cell body lesions of the striatum increase neuron formation (6,7), perhaps through exposure to the correct proliferation signals and a final round of division stem cell survival. However, it is possible that increasing the lesion size further may not be beneficial because within the brain.
While not yet established, it also appears that rapid differentiation into GFAP-positive astro-previous reports suggest that there is a threshold above which damage to the striatum or hippocampus leads to cytes is also not occurring in any of these environments.
We have previously shown that it takes over 20 weeks a reduction in tissue graft survival (23,29). Figure 5 . The type of lesion did not alter the differentiation properties of hNPC GDNF in vivo. Quantification of confocal microscopic analysis revealed that the majority of cells (91.6 ± 1.4% QA, 88.7 ± 2.2% 6-OHDA, 90.4 ± 2.6% unlesioned) remained nestin positive. Only a small percentage of hNuc-positive cells colabeled with GFAP (8.6 ± 1.2% QA, 6.6 ± 1.9% 6-OHDA, 8.3 ± 1.2% unlesioned). There is no significant difference for either the nestin or GFAP results. Only a negligible amount of hNuc-positive cells double labeled with NeuN (<1%; data not shown).
for GFAP-positive astrocytes to develop from hNPC fol-degenerating cells. Thus, we postulate that this feature of the lesion environment providing support for cell mi-lowing transplantation into the 6-OHDA-lesioned striatum (25) , and so perhaps longer time periods are re-gration and survival of human cells will be of high significance when moving forward into clinical trials for quired for full maturation.
GDNF has been shown to protect both dopamine neu-neurodegenerative diseases. The challenge will be to predict the exact lesion environment prior to transplanta-rons and striatal neurons undergoing degeneration in models of Parkinson's and Huntington's disease when tion in order to provide the best dosing of cells and estimate of migration. Further studies in this area using non-delivered directly to the striatum of primates and rodents using in vivo gene therapy approaches (13, 15, 18) . Ex human primates are now essential, and this may be aided by imaging methods such as PET scanning for dopamine vivo approaches in which stem cells are modified to release GDNF and then transplanted offer an interesting metabolism or MRI for striatal atrophy. Assessing the lesion state prior to transplantation and appreciating the alternative that does not require the injection of live virus to the brain. However, to achieve widespread deliv-preference of human neural progenitor cells for certain in vivo environments may provide critical predictive in-ery of GDNF, it will be necessary for the cells to migrate and integrate across wide areas. Our data suggest formation to optimize their survival, migration, and therapeutic potential. that the intact, nondamaged striatum does not provide a good environment for hNPC GDNF migration and delivery.
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